Thomson Reuters Launches Life Sciences Partner Ecosystem to Drive Collaborative R&D Drug Processes

Thomson Reuters Launches Life Sciences Partner Ecosystem to Drive Collaborative R&D Drug Processes

World-leading life science data from Thomson Reuters Cortellis now available to third-party developers

Philadelphia, PA, London, UK, April 23, 2012 — The Intellectual Property & Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today announced the launch of Partner Ecosystem, a new initiative that provides access to Thomson Reuters life sciences information through application-specific solutions developed with third-party partners.

Through Partner Ecosystem, third-party developers take advantage of the Thomson Reuters Cortellis open architecture to access the company's content and technology, creating custom solutions that meet the needs of their customers. These solutions include Thomson Reuters market-leading ontologies, biological target information and additional critical information supporting pharmaceutical business development and competitive intelligence projects. The flexible approach to information delivery enables companies to integrate Thomson Reuters trusted drug pipeline data seamlessly into the daily workflow, delivering on-point information so users can quickly make informed decisions. In addition, partners gain access to the Cortellis Developer Center, a forum where client and third-party developers collaborate to share ideas, best practices, and discuss new applications, as well as obtain technical support from Thomson Reuters technology and content experts.

"We understand the important role our partners play in working with us to support the success of our mutual customers. Partner Ecosystem is a step toward providing the infrastructure and collaboration environment necessary to develop solutions that support the drug R&D process," said Jon Brett-Harris, executive vice president of Life Sciences at Thomson Reuters. "Partner Ecosystem, alongside our portfolio of other advanced solutions, provides the life sciences industry with the necessary tools and information to help address the challenges our customers face."

The Partner Ecosystem web site for developers can be found at http://cortellis.thomsonreuters.com/partners/. To become a partner or learn more, please send an email to [email protected], or connect with Thomson Reuters at the Bio-IT World Conference & Expo, April 24-26, in booth 236.

Contacts

Laura Gaze
Thomson Reuters,
Intellectual Property Solutions
+1.203.868.3340
[email protected] 

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.